Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5697055 | Brachytherapy | 2017 | 5 Pages |
Abstract
Focused extreme dose escalation with low prostate mean peripheral dose results in excellent long-term outcome data and very high focal boost doses and is causing no enhancement in late treatment toxicity.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
György Kovács, Klaudia Müller, Tamer Soror, Corinna Melchert, Xiyuan Guo, Dieter Jocham, Axel Merseburger,